- KR₩316bn
- KR₩400bn
- KR₩174bn
- 31
- 27
- 24
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.7 | ||
| Price to Tang. Book | 3.38 | ||
| Price to Free Cashflow | 60.16 | ||
| Price to Sales | 1.83 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.7% | ||
| Return on Equity | -14.9% | ||
| Operating Margin | -39.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 85,562.37 | 168,310 | 236,120.07 | 187,544.19 | 174,451.44 | n/a | n/a | 24.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +627.23 | -37.5 | -98.06 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GC Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company is principally engaged in the provision of specimen testing services, which are all types of tests performed using specimens collected from patients for the purpose of diagnosing, preventing and treating diseases. The Company is engaged in the development, research, manufacture and distribution of cell therapy products. In addition, the Company is also engaged in the cord blood storage businesses and bio logistic businesses.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 21st, 2011
- Public Since
- June 23rd, 2016
- No. of Shareholders
- 42,423
- No. of Employees
- 427
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 15,027,141
- Address
- 107, Ihyeon-ro 30beon-gil, Giheung-gu, YONGIN, 16924
- Web
- http://gccell.com/
- Phone
- +82 312609300
- Auditors
- Ernst & Young Han Young
Upcoming Events for 144510
Q2 2025 GC Cell Corp Earnings Release
Similar to 144510
Biotoxtech Co
Korea Exchange - KOSDAQ
Chabiotech Co
Korea Exchange - KOSDAQ
DreamCIS
Korea Exchange - KOSDAQ
DT&CRO Co
Korea Exchange - KOSDAQ
Labgenomics Co
Korea Exchange - KOSDAQ
FAQ
What is the GC Cell share price?
As of Today at 20:46 UTC, shares in GC Cell are trading at KR₩21,250. This share price information is delayed by 15 minutes.
How has the GC Cell share price performed this year?
Shares in GC Cell last closed at KR₩21,250 and the price had moved by -43.32% over the past 365 days. In terms of relative price strength the GC Cell share price has underperformed the FTSE Developed Asia Pacific Index by -42.67% over the past year.
What are the analyst and broker recommendations for GC Cell?
The overall consensus recommendation for GC Cell is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the GC Cell dividend yield?
GC Cell does not currently pay a dividend.
Does GC Cell pay a dividend?
GC Cell does not currently pay a dividend.
When does GC Cell next pay dividends?
GC Cell does not currently pay a dividend.
How do I buy GC Cell shares?
To buy shares in GC Cell you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of GC Cell?
As of the previous close price of KR₩21,250, shares in GC Cell had a market capitalisation of KR₩316bn.
Where are GC Cell shares listed?
Here are the trading details for GC Cell:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 144510
What kind of share is GC Cell?
Based on an overall assessment of its quality, value and momentum GC Cell is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a GC Cell share price forecast for 2025?
The analyst consensus target price for shares in GC Cell is KR₩74,881. That is 252.38% above the last closing price of KR₩21,250.
Analysts covering GC Cell currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the GC Cell share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GC Cell. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -33.73%.
As of the last closing price of KR₩21,250, shares in GC Cell were trading -22.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the GC Cell PE Ratio?
The GC Cell PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩21,250.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of GC Cell?
GC Cell's management team is headed by:
- Dae Wu Park - CEO